Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medimaging Integrated SolutionTPE:6796 +2.93%76 5-Year Yield-on-Cost % is 0.45 as of Jul. 31, 2026, which is 78% below its 10-year median of 2.08. GuruFocus rates TPE:6796 with a GF Score™ of 76/100 and a GF Value™ of NT$103.58 (Possible Value Trap). The stock has 11 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Medimaging Integrated Solution ranks worse than 89.34% on this metric.
The historical rank and industry rank for Medimaging Integrated Solution's 5-Year Yield-on-Cost % or its related term are showing as below:
TPE:6796'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.45 Med: 2.08 Max: 5.96
Current: 0.45
During the past 8 years, Medimaging Integrated Solution's highest Yield on Cost was 5.96. The lowest was 0.45. And the median was 2.08.
TPE:6796's 5-Year Yield-on-Cost % is ranked worse than 89.34% of 319
companies
in the Medical Devices & Instruments industry
Industry Median: 2.45
vs TPE:6796: 0.45
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Medimaging Integrated Solution 5-Year Yield-on-Cost % Related Terms
TPE:6796 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Medimaging Integrated Solution's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medimaging Integrated Solution 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medimaging Integrated Solution's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Medimaging Integrated Solution's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Medimaging Integrated Solution (TPE:6796) has a 5-Year Yield-on-Cost % of 0.45 as of Jul. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medimaging Integrated Solution and its competitors. This is 78% below median its historical median of 2.08. Over the past decade, Medimaging Integrated Solution's 5-Year Yield-on-Cost % has ranged from 0.45 to 5.96. According to the industry distribution chart, Medimaging Integrated Solution ranks #285 out of 319 companies in the Medical Devices & Instruments industry, placing it in the top 89.3%.
Is Medimaging Integrated Solution's 5-Year Yield-on-Cost % too high?
Medimaging Integrated Solution's current 5-Year Yield-on-Cost % of 0.45 is 78% below median its 10-year median of 2.08. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 5.96. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.45. Medimaging Integrated Solution's value of 0.45 is 81.6% below this industry median. Based on the distribution chart, Medimaging Integrated Solution ranks #285 out of 319 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medimaging Integrated Solution has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medimaging Integrated Solution's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medimaging Integrated Solution ranks #285 out of 319 companies for 5-Year Yield-on-Cost %. This places Medimaging Integrated Solution in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.45. Medimaging Integrated Solution's value of 0.45 is 81.6% below this benchmark. Historically, Medimaging Integrated Solution's own 5-Year Yield-on-Cost % has ranged from 0.45 to 5.96 over the past decade. While the company's 10-year median is 2.08 vs. the industry median of 2.45, Medimaging Integrated Solution has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.45, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medimaging Integrated Solution's current 5-Year Yield-on-Cost % of 0.45 is 81.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Medimaging Integrated Solution and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medimaging Integrated Solution's current 5-Year Yield-on-Cost % is 0.45, which is 78% below median its own 10-year median of 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medimaging Integrated Solution stock overvalued right now?
Based on GuruFocus' analysis, Medimaging Integrated Solution (TPE:6796) is currently considered Possible Value Trap. The stock's GF Value™ is NT$103.58, compared to a current price of NT$56.30 — trading 45.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.45, which is 78% below median its 10-year median of 2.08 and 81.6% below the Medical Devices & Instruments industry median of 2.45. Medimaging Integrated Solution's overall GF Score™ is 76/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Medimaging Integrated Solution (TPE:6796), the current 5-Year Yield-on-Cost % is 0.45 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medimaging Integrated Solution (TPE:6796) Overvalued in 2026?
Based on GuruFocus' analysis, Medimaging Integrated Solution stock appears to be undervalued.
The current stock price of NT$56.30 is trading 45.6% below its estimated GF Value™ of NT$103.58.
GuruFocus considers Medimaging Integrated Solution to be Possible Value Trap.
Key valuation signals for TPE:6796:
5-Year Yield-on-Cost %: 0.45 (78% below median its 10-year median of 2.08)
GF Value™: NT$103.58 vs. price of NT$56.30 (45.6% below fair value)
Industry Position: 81.6% below the Medical Devices & Instruments median (#285 of 319)
No single metric tells the full story. See the TPE:6796 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medimaging Integrated Solution Inc and its subsidiaries are engaged in the design, manufacturing, and sales of digital medical imaging diagnostic equipment and related products and services. The company is a trusted partner of hospitals, medical schools, and health organizations, providing practitioners with digital and portable diagnostic solutions. The company designs and manufactures digital hand-held diagnostic scopes. Its products include Horus Scope, Smart Solutions, Endoscopy, and Micro Camera Modules.
76GF Score
Get the complete analysis for TPE:6796
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6796 has been successfully added to your 
